Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Conditions
- Gastrinoma
- Glucagonoma
- Insulinoma
- Metastatic Gastrointestinal Carcinoid Tumor
- Pancreatic Polypeptide Tumor
- Pulmonary Carcinoid Tumor
- Recurrent Gastrointestinal Carcinoid Tumor
- Recurrent Islet Cell Carcinoma
- Somatostatinoma
Interventions
- DRUG: regorafenib
- OTHER: laboratory biomarker analysis
Sponsor
University of Southern California
Collaborators